Home » Stocks » SIGA

SIGA Technologies Inc. (SIGA)

Stock Price: $6.39 USD 0.09 (1.43%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
Market Cap 473.12M
Revenue (ttm) 127.15M
Net Income (ttm) 64.43M
Shares Out 76.07M
EPS (ttm) 0.81
PE Ratio 7.89
Forward PE 8.13
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $6.39
Previous Close $6.30
Change ($) 0.09
Change (%) 1.43%
Day's Open 6.37
Day's Range 6.30 - 6.45
Day's Volume 178,385
52-Week Range 5.66 - 8.10

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference c...

13 hours ago - GlobeNewsWire

NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has en...

1 day ago - GlobeNewsWire

NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it provid...

4 weeks ago - GlobeNewsWire

Searching for undervalued biotech stocks? Here are 4 biotech stocks to buy for a mix of value and growth in any portfolio.

Other stocks mentioned: BIIB, INVA, SAGE
1 month ago - InvestorPlace

Small-cap stocks in the biotech space have been in a slump, but these seven companies could see big moves just around the corner. The post 7 Small-Cap Biotech Stocks to Watch for Upcoming Catalysts appe...

Other stocks mentioned: AGEN, ATOS, CDMO, COCP, OCGN, SIOX
2 months ago - InvestorPlace

- Important for Patients Who Cannot Swallow Oral Capsules - - Important for Patients Who Cannot Swallow Oral Capsules -

2 months ago - GlobeNewsWire

NEW YORK, March 23, 2021 (GLOBE NEWSWIRE) -- Cipla Therapeutics, a division of Cipla USA Inc., an affiliate of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; referred to as "Cipla") and SIGA Technologies, I...

4 months ago - GlobeNewsWire

-  Approximately 363,000 Courses of Oral TPOXX® Delivered to U.S. Government in 2020 –

4 months ago - GlobeNewsWire

NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that managemen...

5 months ago - GlobeNewsWire

If you want to increase your chances of beating the market, one method is to select stocks that rank highly according to the "Magic Formula" criteria.

Other stocks mentioned: ENDP, GIB
5 months ago - GuruFocus

Second Contract by a Canadian Governmental Agency for the Procurement of Oral TPOXX

6 months ago - GlobeNewsWire

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Denni...

8 months ago - GlobeNewsWire

SIGA Technologies, Inc. (SIGA) CEO Phillip Gomez on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

- Third Quarter includes Delivery of Approximately 134,000 Courses of TPOXX® to U.S. Government –

8 months ago - GlobeNewsWire

NEW YORK, Oct. 29, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that managemen...

9 months ago - GlobeNewsWire

NEW YORK, Oct. 08, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the Publi...

9 months ago - GlobeNewsWire

NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Ph...

10 months ago - GlobeNewsWire

NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Den...

10 months ago - GlobeNewsWire

SIGA Technologies' (SIGA) CEO Phil Gomez on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

- Second Quarter includes Deliveries to SNS and First International Delivery -

11 months ago - GlobeNewsWire

NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that managem...

11 months ago - GlobeNewsWire

- Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications -

11 months ago - GlobeNewsWire

First Deliveries of Contract Option Exercises Announced in April 2020

1 year ago - GlobeNewsWire

NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the Uni...

1 year ago - GlobeNewsWire

- 2,500 Courses Delivered to the Canadian Department of National Defence -

1 year ago - GlobeNewsWire

SIGA Technologies, Inc. (SIGA) CEO Phillip Gomez on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

NEW YORK, April 29, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that manage...

1 year ago - GlobeNewsWire

- Contract for up to $14.3 million for 15,325 Courses -

1 year ago - GlobeNewsWire

SIGA Technologies, Inc. (SIGA) CEO Phil Gomez on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

SIGA to supply TPOXX® To Support Turnstone’s SKV Vaccinia Oncolytic Viral Immunotherapy Program

1 year ago - GlobeNewsWire

NEW YORK, Dec. 05, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the Can...

1 year ago - GlobeNewsWire

NEW YORK, Nov. 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the Can...

1 year ago - GlobeNewsWire

NEW YORK, Oct. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phi...

1 year ago - GlobeNewsWire

A number of Wall Street's rising hedge fund managers revealed their top stock picks at the annual Sohn San Francisco Investment Conference.

Other stocks mentioned: AFYA, BL, ADYEY
1 year ago - CNBC

NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Ph...

1 year ago - GlobeNewsWire

NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. De...

1 year ago - GlobeNewsWire

NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phi...

1 year ago - GlobeNewsWire

About SIGA

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was founded in 1995 and is headquartered in New York, New York.

Industry
Biotechnology
IPO Date
Sep 9, 1997
Stock Exchange
NASDAQ
Ticker Symbol
SIGA
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for SIGA is 11.00, which is an increase of 72.14% from the latest price.

Price Target
$11.00
(72.14% upside)